Ivermectin
Ivermectin Medical Valley contains the active substance ivermectin. The medicine is used to treat infections caused by certain parasites.
The medicine is used to treat:
Ivermectin Medical Valley does not prevent the occurrence of these infections. It does not work against mature forms of the worm. Ivermectin Medical Valley should only be taken if the doctor has confirmed or suspects a parasitic infection.
Generally, if unusual symptoms occur suddenly after taking any medicine, such as rash, hives, or fever, it can be suspected that the patient is allergic to the medicine.
Before starting to take Ivermectin Medical Valley, discuss it with your doctor or pharmacist.
Severe skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported with ivermectin. You should stop taking ivermectin and seek medical attention immediately if you experience any of the symptoms of severe skin reactions listed in section 4.
In particular, you should tell your doctor if you:
Taking the medicine called diethylcarbamazine citrate (DEC) at the same time to treat co-existing Onchocerca volvulus infection may increase the risk of severe side effects.
If any of the above applies to you (or you are not sure), you should consult your doctor or pharmacist before taking Ivermectin Medical Valley.
Ivermectin Medical Valley is not intended to prevent tropical parasitic infections. It is not effective against mature forms of parasites and can only be used on the advice of a doctor when a parasitic infection has been confirmed or suspected.
It is not known whether Ivermectin Medical Valley can be safely used in children with a body weight below 15 kg.
Tell your doctor or pharmacist about all medicines you are taking, or have recently taken, and about any medicines you plan to take.
If you are pregnant, breastfeeding, think you may be pregnant, or plan to have a child, you should ask your doctor or pharmacist for advice before taking this medicine.
The effect of Ivermectin Medical Valley on the ability to drive and use machines has not been studied. In some patients, side effects such as dizziness, drowsiness, tremors, or a feeling of spinning may occur, which may affect the ability to drive and use machines.
If you experience such symptoms, you should avoid driving and using machines.
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
Treatment consists of a single dose.
Microfilaraemia caused by lymphatic filariasis caused by Wuchereria bancrofti
Body Weight (kg) | Dose (number of 3 mg tablets) |
from 15 to 24 | One |
from 25 to 35 | Two |
from 36 to 50 | Three |
from 51 to 65 | Four |
from 66 to 79 | Five |
> 80 | Six |
Body Weight (kg) | Dose when administered every 6 months (number of 3 mg tablets) | Dose when administered every 12 months (number of 3 mg tablets) |
from 15 to 25 | One | Two |
from 26 to 44 | Two | Four |
from 45 to 64 | Three | Six |
from 65 to 84 | Four | Eight |
Height (in cm) | Dose when administered every 6 months (number of 3 mg tablets) | Dose when administered every 12 months (number of 3 mg tablets) |
from 90 to 119 | One | Two |
from 120 to 140 | Two | Four |
from 141 to 158 | Three | Six |
> 158 | Four | Eight |
If you feel that the effect of Ivermectin Medical Valley is too strong or too weak, you should consult your doctor or pharmacist.
Take this medicine exactly as your doctor has told you. In some patients, decreased consciousness, including coma, has been reported after overdosing on ivermectin.
If you take more Ivermectin Medical Valley than you should, contact your doctor immediately.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Always follow the instructions of your doctor. Do not take a double dose to make up for a forgotten dose.
Like all medicines, Ivermectin Medical Valley can cause side effects, although not everybody gets them.
Side effects are usually not serious and do not last long. They are more likely to occur in people infected with several parasites and especially in people infected with the Loa loa worm.
The following side effects may occur when taking this medicine:
If you experience an allergic reaction, you should seek medical attention immediately. Symptoms may include:
If you experience any of the above side effects, you should seek medical attention immediately.
You should stop taking ivermectin and seek medical attention immediately if you notice any of the following symptoms:
The following side effects depend on the purpose for which Ivermectin Medical Valley is used and whether the patient has any other infections.
In people with intestinal strongyloidiasis (anguillulosis), the following side effects may occur:
In people with microfilaraemia due to lymphatic filariasis caused by Wuchereria bancrofti, the following side effects may occur:
In people with scabies, the following side effects may occur:
In people with severe Loa loa infection, the following side effects may occur:
In people infected with the Onchocerca volvulus parasite, which causes river blindness, the following side effects may occur:
If you experience any side effects, including any not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181 C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and carton after “Expiry Date” (EXP). The expiry date refers to the last day of that month.
There are no special storage instructions for this medicine.
Store in the original package to protect from light.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The medicine is in the form of round, white tablets without markings.
The medicine is available in aluminum/aluminum blisters containing 4, 8, 12, or 20 tablets in a cardboard box.
Not all pack sizes may be marketed.
Medical Valley Invest AB, Brädgårdsvägen 28, 236 32 Höllviken, Sweden, email: safety@medicalvalley.se
Laboratorios Liconsa, S.A., Polígono Industrial Miralcampo, Avda. Miralcampo, 7, 19200 Azuqueca de Henares – Guadalajara, Spain
Medical Valley Invest AB, Brädgårdsvägen 28, 236 32 Höllviken, Sweden
Austria: Ivergelan 3 mg Tablets
Denmark: Ivermectin “Medical Valley”, tablets
Finland: Ivermectin Medical Valley 3 mg tablets
France: Ivermectine Liconsa 3 mg tablet
Netherlands: Ivermectine Xiromed 3 mg, tablets
Iceland: Ivermectin Medical Valley 3 mg tablets
Germany: Iveraxiro 3 mg Tablets
Norway: Ivermectin Medical Valley
Poland: Ivermectin Medical Valley
Portugal: Ivermectina Cantabria 3 mg tablets
Czech Republic: Ivermectin Exeltis 3 mg tablets
Slovakia: Ivermectin Exeltis 3 mg tablets
Sweden: Ivermectin Medical Valley 3 mg tablets
Italy: Ivermectina Difa
Date of last revision of the leaflet:10/2024
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.